Tag: narrow therapeutic index

April 8, 2026

Generic Drugs vs Brand Name: Are Side Effects More Likely?

Are generic drugs as safe as brand names? We explore bioequivalence, the nocebo effect, and why some patients experience different side effects after switching.

Read More

February 16, 2026

Professional Liability and Generic Substitution: Reducing Risk for Pharmacists

Pharmacists face growing legal risk when substituting generic drugs, especially for narrow therapeutic index medications. Learn how state laws, federal preemption, and patient consent impact liability-and what steps you can take today to protect yourself.

Read More

November 20, 2025

Bridging Studies for NTI Generics: Ensuring Safety and Efficacy in Generic Drug Approval

Bridging studies for NTI generics ensure that life-critical generic drugs like warfarin and levothyroxine are as safe and effective as brand versions. These complex studies use tighter criteria and advanced designs to protect patients.

Read More